Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AMA Delegates Dismayed With Prevention Task Force

This article was originally published in The Gray Sheet

Executive Summary

A new American Medical Association policy expresses “concern” over the U.S. Preventive Services Task Force's recommendations on mammography and PSA screening. In the future, the task force should obtain input from disease specialists, it says. Some members of Congress agree.


Related Content

PSA Prostate Cancer Screening Does More Harm Than Good, USPSTF Concludes
Task Force Mammography Guidelines Present Challenges And Opportunities





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts